RESET PHARMACEUTICALS
Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments for patients with life-threatening illnesses, including cancer. Its program focuses on psilocybin with psychotherapy for patients with cancer-related demoralization, anxiety, and depression.
RESET PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical
Website Url:
http://www.resetpharma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
11.12 M USD
Similar Organizations
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
Montecito Bio Sciences, Ltd.
Bio-medical diagnostics company focused on the development and exploitation of a proprietary diagnostic and monitoring platform.
Official Site Inspections
http://www.resetpharma.com
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Reset Pharmaceuticals"
Contact Us - Reset Pharma
Reset Pharma Contact Form Contact Us Reset Pharmaceuticals, Inc. [email protected]See details»
Our Focus – Reset Pharma
Demoralization syndrome is a significant mental health condition characterized by loss of hope, purpose, and meaning in one’s life. It can occur in patients facing end-of-life progressive diseases such as cancer. 1See details»
Our Team – Reset Pharma
Our leadership team is composed of scientific and strategic professionals at the forefront of CNS research & development and commercialization, and is strengthened further by leaders in psychology, psychiatry, psychedelics, and …See details»
Reset Pharmaceuticals - LinkedIn
Reset Pharmaceuticals | 478 followers on LinkedIn. Advancing Novel Psychedelic Medicines to Improve Mental Health in Persons with Life-threatening Illness | Reset Pharma is a privately …See details»
Newsroom – Reset Pharma
Stephen Ross, M.D., Chair of Reset Pharma’s Scientific Advisory Board to Deliver Keynote Presentation at The End in Mind Virtual ConferenceSee details»
Reset Pharma – Reset Pharma
Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development and commercialization of novel clinical-stage treatments for patients suffering …See details»
Press Release – Reset Pharma
Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development and commercialization of novel clinical-stage treatments for patients suffering …See details»
Reset Pharmaceuticals - Crunchbase Company Profile …
Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.See details»
Reset Pharmaceuticals Information - RocketReach
Reset Pharmaceuticals is a Biotechnology Research company with 2 employees. Find top employees, contact details and business statistics at RocketReach.See details»
Synapse - Global Drug Intelligence Database
May 7, 2025 Synapse is a global drug intelligence database for pharmaceutical companies, investment institutions and industrial parks. It provides complete and integrated R&D …See details»
Reset Pharmaceuticals Overview | SignalHire Company Profile
Reset Pharma is a privately-held biotechnology company focused on the development and commercialization of novel psychedelic treatments for patients with life-threatening illnesses, …See details»
Reset Pharma - neuly.com
Reset Pharma is developing novel, innovative treatments to restore the quality of life to patients with life-threatening cancer experiencing clinically relevant demoralization, anxiety and …See details»
Reset Pharma | VentureRadar
Reset Pharma is a privately held, US-based biotechnology company developing and commercializing novel clinical-stage treatments for patients suffering from mental illness …See details»
Reset Pharmaceuticals Company Profile | Management and
Find contact information for Reset Pharmaceuticals. Learn about their Pharmaceuticals, Manufacturing market share, competitors, and Reset Pharmaceuticals's email format.See details»
Reset Pharmaceuticals Enters into Exclusive Worldwide License …
Jul 7, 2021 Transaction accelerates Reset Pharmaceuticals’ lead psilocybin program, targeting severe demoralization, as well as anxiety, and depression, in cancer patients Stephen Ross, …See details»
Reset Pharma - Products, Competitors, Financials, Employees ...
Reset Pharma is a neuro-biotechnology company that develops psychedelic treatments for mental health issues related to life-threatening illnesses. Use the CB Insights Platform to explore …See details»
UPDATE -- Reset Pharmaceuticals Enters into Exclusive Worldwide …
Jul 7, 2021 Transaction accelerates Reset Pharmaceuticals’ lead psilocybin program, targeting severe demoralization, as well as anxiety, and depression, in cancer patients Stephen Ross, …See details»
Reset Pharmaceuticals Appoints Innes Meldrum as President
Jan 5, 2023 Reset Pharmaceuticals Appoints Innes Meldrum as President and Chief Executive Officer January 05, 2023 08:00 ET | Source: Reset Pharmaceuticals Inc.See details»
Reset Pharma 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Reset Pharma. Use the PitchBook Platform to explore the full profile.See details»
Reset Pharmaceuticals - SPEEDA Edge
Reset Pharma is a biotechnology firm focused on creating innovative treatments for patients with life-threatening diseases, particularly those suffering from cancer-related mental health issues …See details»